Mercer Global Advisors Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Mercer Global Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.28 - $1.16 $31,315 - $129,736	-111,842 Reduced 67.03%	55,010 $18,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $29,813 - $46,970	28,126 Added 20.27%	166,852 $194,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $104,629 - $148,639	-83,039 Reduced 37.44%	138,726 $234,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $195,896 - $309,054	121,675 Added 121.57%	221,765 $401,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $96,780 - $165,545	84,895 Added 558.7%	100,090 $186,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $3,724 - $6,797	-3,104 Reduced 16.96%	15,195 $20,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $9,515 - $20,549	5,838 Added 46.85%	18,299 $31,000
Q3 2022 Nov 15, 2022	BUY	$0.73 - $3.74 $1,686 - $8,639	2,310 Added 22.76%	12,461 $39,000
Q2 2022 Aug 10, 2022	BUY	$2.2 - $4.2 $22,332 - $42,634	10,151 New	10,151 $24,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.